Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Global Value Dossier

- PMLiVE

Gottlieb heading to FDA after clearing Senate vote

Trump’s favoured candidate received bipartisan support despite criticism

- PMLiVE

Focus on Rare Diseases

As pharma becomes more focused on rare disease therapies, Lucid Group recognises that medical education agencies need to respond.

Lucid Group Communications Limited

- PMLiVE

When science is not enough

Mundipharma’s Will Dunlop on a new framework to guide development programmes to a better destination

- PMLiVE

Kymab appoints its first chief medical officer

Dr Sonia Quaratino joins the firm from Novartis

- PMLiVE

Pfizer launches antibiotic resistance surveillance website

Designed for healthcare professional use ATLAS will cover 60 countries

- PMLiVE

Just 20% of people living with hep C are aware of their status

WHO's hepatitis report reveals global impact of the disease

- PMLiVE

Notch Communications relocates to new Manchester offices

Agency takes up residence in city centre's Neo building

- PMLiVE

UK pharma apprehensive about post-Brexit investment

ABPI calls for a return of the 'white heat' of innovation to the UK

Sanofi reception

Sanofi agrees €250m diabetes deal with AI firm Exscientia

The French pharma giant will pay royalties and contribute research funding

- PMLiVE

Uniphar acquires specialist sales firm OUTiCO

It will continue to be led by founders Paul Black and Mike Cooper

- PMLiVE

Activists torpedo Immunomedics deal with Seattle Genetics

venBio says deal will enrich CEO at shareholders' expense

Perfect Timing?

Timing is often the reason for embracing a new approach "this is ideal timing for our strategic planning", yet can also be a major barrier for doing more of the same...

Lucid Group Communications Limited

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links